Tempus to acquire Personalis for $1.5 billion
20/07/2026 13:37
Tempus to acquire Personalis for $1.5 billion July 20 (Reuters) - Tempus AI TEM.O said on Monday it would acquire Personalis PSNL.O for about $1.5 billion to bringing its cancer test to the AI-enabled precision medicine firm's oncology portfolio.
(Reporting by Christy Santhosh in Bengaluru; Editing by Anil D'Silva)
Recent news on Personalis
See all newsBrief: Personalis - Announces Commercial Launch Of Real-Time Variant Tracker In Next Personal Mrd Test
U.S. STOCKS ON THE MOVE-Becton Dickinson, Constellation Energy, Marvell
Personalis slips as BTIG downgrades, sees no rival bid for Tempus deal
Brief: Personalis Receives New Task Order Under U.S. Veterans Affairs Contract For VA MVP
Personalis, Inc. reports results for the quarter ended June 30 - Earnings Summary